Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.56 - $1.0 $1.73 Million - $3.08 Million
-3,084,150 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.9 - $8.39 $840,249 - $7.83 Million
-933,610 Reduced 23.24%
3,084,150 $2.79 Million
Q4 2021

Feb 11, 2022

SELL
$6.58 - $8.44 $8.78 Million - $11.3 Million
-1,334,085 Reduced 24.93%
4,017,760 $32.2 Million
Q3 2021

Nov 15, 2021

BUY
$5.16 - $8.47 $8.51 Million - $14 Million
1,648,814 Added 44.53%
5,351,845 $44.8 Million
Q2 2021

Aug 16, 2021

BUY
$5.75 - $7.59 $1.78 Million - $2.34 Million
308,785 Added 9.1%
3,703,031 $25 Million
Q1 2021

May 17, 2021

SELL
$4.14 - $9.22 $254,688 - $567,205
-61,519 Reduced 1.78%
3,394,246 $22.4 Million
Q4 2020

Feb 12, 2021

SELL
$3.58 - $4.85 $4.53 Million - $6.14 Million
-1,266,475 Reduced 26.82%
3,455,765 $14.5 Million
Q3 2020

Nov 16, 2020

SELL
$4.79 - $6.3 $700,178 - $920,902
-146,175 Reduced 3.0%
4,722,240 $22.6 Million
Q2 2020

Aug 14, 2020

SELL
$4.5 - $6.53 $827,442 - $1.2 Million
-183,876 Reduced 3.64%
4,868,415 $29.6 Million
Q1 2020

May 14, 2020

SELL
$5.25 - $9.9 $2.32 Million - $4.38 Million
-442,837 Reduced 8.06%
5,052,291 $27.7 Million
Q4 2019

Feb 11, 2020

BUY
$5.84 - $10.51 $32.1 Million - $57.8 Million
5,495,128 New
5,495,128 $54.5 Million

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $184M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.